| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.078 | 0.09 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.066 | 0.1 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.063 | 0.2 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.056 | 0.2 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.054 | 0.3 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.048 | 0.3 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.048 | 0.4 |